Skip to content
OpenCapital
Get started

Bioventus BVS Line of credit facility, number of LOCs outstanding

Other financials

Income statement

See full
Revenue$132.1M+6.6%
Gross profit$90.8M+9.3%
Operating income$8.4M+72.8%
Net income$3.1M+218%
EPS (diluted)$0.04+200%

Balance sheet

See full
Cash & equivalents$35.8M+57.2%
Total debt$288.4M-21.2%
Total equity$188.9M+27.5%
Total assets$650.5M-5.9%

Cash flow

See full
Operating cash flow$8.9M+146%
CapEx$574.0K-30.5%
Free cash flow$8.4M+141%

Valuation

See full
Market cap$659.19M+51.7%
Enterprise value$911.76M+17.2%
P/E23.1×—
P/S1.1×+0.4×

Profitability

See full
Gross margin68.7%+1.2pp
Operating margin10%—
Net margin4.9%+3.2pp
FCF margin17.5%+13.2pp

Returns & leverage

See full
Return on equity16.9%+10.9pp
Debt / equity1.5×-0.9×
Current ratio1.7×+0.3×

Where this comes from

Reported directly by Bioventus in its filing.

Tagged under the XBRL concept bvs:LineOfCreditFacilityNumberOfLettersOfCreditOutstanding.

The official record: Bioventus’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bioventus's line of credit facility, number of locs outstanding.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bioventus's line of credit facility, number of locs outstanding?
Bioventus (BVS) reported line of credit facility, number of locs outstanding of 3 in Q1 2026.
How has Bioventus's line of credit facility, number of locs outstanding changed year-over-year?
Bioventus's line of credit facility, number of locs outstanding decreased by 0.0% year-over-year, from 3 to 3.
What is the long-term trend for Bioventus's line of credit facility, number of locs outstanding?
Over 2 years (2023 to 2025), Bioventus's line of credit facility, number of locs outstanding has grown at a 0.0% compound annual growth rate (CAGR), from 3 to 3.